United Therapeutics (UTHR) Granted FDA Approval Of Third Generation Nebulizer For Tyvaso Inhalation System

October 23, 2017 6:00 AM

United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA) of a new inhalation ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found